COMPANY
ADAXION Therapeutics
Our platform enables biotherapeutics that would otherwise have prohibitive immunogenicity, driven by a drug’s pharmacology or its intrinsic foreignness. From company website Source · Oct 13, 2026
COMPANY
Our platform enables biotherapeutics that would otherwise have prohibitive immunogenicity, driven by a drug’s pharmacology or its intrinsic foreignness. From company website Source · Oct 13, 2026